california biotech cbio sees st qtr loss california biotechnology inc said expects report loss dlrs dlrs first quarter due increased investment research manufacturing scaleup production company said research spending running pct year ago tries commercialize products quickly possible increased expenditures expected continue several quarters said operating results fluctuate quarter quarter depending timing significant payments commercial partners first three months company lost dlrs company changed fiscal year calendar year year ending november first quarter last year ended february california biotech earned dlrs reuter